Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia. Mediterr J Hematol Infect Dis [Internet]. 2016 Feb. 20 [cited 2026 May 2];8:e2016016. Available from: https://www.mjhid.org/mjhid/article/view/2016.016